NCT00575367

Study of AzaSite Versus Vigamox in the Tears of Healthy Volunteers

A Single-Center, Open-Label, Randomized Study of the Pharmacokinetics of AzaSite Ophthalmic Solution Versus Vigamox in the Tears of Healthy Volunteers Following a Single Ocular Administration

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 37 (actual)
• Sponsor: Merck Sharp & Dohme LLC · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the drug concentrations of AzaSite compared to Vigamox in tears of healthy volunteers

Conditions

• Bacterial Infections
• Eye Infections

Interventions

Type	Name	Description
DRUG	AzaSite (azithromycin ophthalmic solution)	One drop ophthalmic solution at Visit 2
DRUG	Vigamox (moxifloxacin hydrochloride ophthalmic solution)	One drop ophthalmic solution at Visit 2

Timeline

• Start date: 2008-03-01
• Primary completion: 2008-10-01
• First posted: 2007-12-18
• Last updated: 2011-09-22
• Results posted: 2009-09-17

Locations

1 site across 1 country: United States